CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.32B
1-Year Est. Return 52.43%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+52.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
543
New
Increased
Reduced
Closed

Top Buys

1 +$16.2M
2 +$6.26M
3 +$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

1 +$11.5M
2 +$7.75M
3 +$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
376
Enliven Therapeutics
ELVN
$2.45B
$149K 0.01%
9,671
-712
GOSS icon
377
Gossamer Bio
GOSS
$82.2M
$148K 0.01%
+47,716
KURA icon
378
Kura Oncology
KURA
$849M
$147K 0.01%
14,179
-1,035
MESO
379
Mesoblast
MESO
$2.04B
$144K 0.01%
7,992
-284
ESPR icon
380
Esperion Therapeutics
ESPR
$808M
$144K 0.01%
38,955
+3,614
CRVS icon
381
Corvus Pharmaceuticals
CRVS
$1.23B
$140K 0.01%
18,169
+5,108
GERN icon
382
Geron
GERN
$936M
$137K 0.01%
104,020
-7,815
VIR icon
383
Vir Biotechnology
VIR
$1.66B
$137K 0.01%
22,670
-1,680
ON icon
384
ON Semiconductor
ON
$39.4B
$135K 0.01%
2,500
-10,797
AVBP icon
385
ArriVent BioPharma
AVBP
$1.37B
$135K 0.01%
6,727
-384
JANX icon
386
Janux Therapeutics
JANX
$891M
$135K 0.01%
9,801
-733
KALV icon
387
KalVista Pharmaceuticals
KALV
$1.42B
$133K 0.01%
8,236
-588
ORIC icon
388
Oric Pharmaceuticals
ORIC
$912M
$130K 0.01%
15,870
-11,154
AQST icon
389
Aquestive Therapeutics
AQST
$526M
$128K 0.01%
19,880
-1,325
GHRS icon
390
GH Research
GHRS
$1.54B
$128K 0.01%
+10,107
RIGL icon
391
Rigel Pharmaceuticals
RIGL
$493M
$127K 0.01%
2,958
-186
TECX
392
Tectonic Therapeutic
TECX
$547M
$126K 0.01%
6,050
-830
PAHC icon
393
Phibro Animal Health
PAHC
$2.37B
$124K 0.01%
3,332
-238
REPL icon
394
Replimune Group
REPL
$276M
$124K 0.01%
12,782
-900
ARVN icon
395
Arvinas
ARVN
$657M
$124K 0.01%
10,465
-2,404
TMDX icon
396
Transmedics
TMDX
$2.52B
$122K 0.01%
1,000
ABSI icon
397
Absci
ABSI
$894M
$120K 0.01%
34,503
+8,294
RGNX icon
398
Regenxbio
RGNX
$528M
$119K 0.01%
8,249
-605
LXEO icon
399
Lexeo Therapeutics
LXEO
$489M
$118K 0.01%
11,893
+2,427
CTMX icon
400
CytomX Therapeutics
CTMX
$871M
$118K 0.01%
+27,609